Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders

Blood - Tập 114 - Trang 5473-5480 - 2009
Zhaohui Ye1,2, Huichun Zhan3, Prashant Mali1,4, Sarah Dowey1, Donna M. Williams3, Yoon-Young Jang5, Chi V. Dang3, Jerry L. Spivak3, Alison R. Moliterno3, Linzhao Cheng1,2,3
1Stem Cell Program, Institute for Cell Engineering, and Department of Gynecology & Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD
2Graduate Immunology Program, Johns Hopkins University, Baltimore, MD
3Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD
4Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD
5Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD

Tóm tắt

Abstract Human induced pluripotent stem (iPS) cells derived from somatic cells hold promise to develop novel patient-specific cell therapies and research models for inherited and acquired diseases. We and others previously reprogrammed human adherent cells, such as postnatal fibroblasts to iPS cells, which resemble adherent embryonic stem cells. Here we report derivation of iPS cells from postnatal human blood cells and the potential of these pluripotent cells for disease modeling. Multiple human iPS cell lines were generated from previously frozen cord blood or adult CD34+ cells of healthy donors, and could be redirected to hematopoietic differentiation. Multiple iPS cell lines were also generated from peripheral blood CD34+ cells of 2 patients with myeloproliferative disorders (MPDs) who acquired the JAK2-V617F somatic mutation in their blood cells. The MPD-derived iPS cells containing the mutation appeared normal in phenotypes, karyotype, and pluripotency. After directed hematopoietic differentiation, the MPD-iPS cell-derived hematopoietic progenitor (CD34+CD45+) cells showed the increased erythropoiesis and gene expression of specific genes, recapitulating features of the primary CD34+ cells of the corresponding patient from whom the iPS cells were derived. These iPS cells provide a renewable cell source and a prospective hematopoiesis model for investigating MPD pathogenesis.

Tài liệu tham khảo

Takahashi, 2007, Induction of pluripotent stem cells from adult human fibroblasts by defined factors., Cell, 131, 861, 10.1016/j.cell.2007.11.019 Yu, 2007, Induced pluripotent stem cell lines derived from human somatic cells., Science, 318, 1917, 10.1126/science.1151526 Park, 2008, Reprogramming of human somatic cells to pluripotency with defined factors., Nature, 451, 141, 10.1038/nature06534 Mali, 2008, Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts., Stem Cells, 26, 1998, 10.1634/stemcells.2008-0346 Lowry, 2008, Generation of human induced pluripotent stem cells from dermal fibroblasts., Proc Natl Acad Sci U S A, 105, 2883, 10.1073/pnas.0711983105 Dimos, 2008, Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons., Science, 321, 1218, 10.1126/science.1158799 Ebert, 2009, Induced pluripotent stem cells from a spinal muscular atrophy patient., Nature, 457, 277, 10.1038/nature07677 Park, 2008, Disease-specific induced pluripotent stem cells., Cell, 134, 877, 10.1016/j.cell.2008.07.041 Hanna, 2008, Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency., Cell, 133, 250, 10.1016/j.cell.2008.03.028 Okabe, 2009, Definitive proof for direct reprogramming of hematopoietic cells to pluripotency., Blood, 114, 1764, 10.1182/blood-2009-02-203695 Loh, 2009, Generation of induced pluripotent stem cells from human blood., Blood, 113, 5476, 10.1182/blood-2009-02-204800 Anderlini, 2009, Effects and safety of granulocyte colony-stimulating factor in healthy volunteers., Curr Opin Hematol, 16, 35, 10.1097/MOH.0b013e328319913c James, 2005, A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera., Nature, 434, 1144, 10.1038/nature03546 Kralovics, 2005, A gain-of-function mutation of JAK2 in myeloproliferative disorders., N Engl J Med, 352, 1779, 10.1056/NEJMoa051113 Levine, 2005, Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis., Cancer Cell, 7, 387, 10.1016/j.ccr.2005.03.023 Zhao, 2005, Identification of an acquired JAK2 mutation in polycythemia vera., J Biol Chem, 280, 22788, 10.1074/jbc.C500138200 Baxter, 2005, Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders., Lancet, 365, 1054, 10.1016/S0140-6736(05)71142-9 Moliterno, 2006, Molecular mimicry in the chronic myeloproliferative disorders: reciprocity between quantitative JAK2 V617F and Mpl expression., Blood, 108, 3913, 10.1182/blood-2006-03-008805 Moliterno, 2008, Phenotypic variability within the JAK2 V617F-positive MPD: roles of progenitor cell and neutrophil allele burdens., Exp Hematol, 36, 1480, 10.1016/j.exphem.2008.05.006 Ugo, 2004, Multiple signaling pathways are involved in erythropoietin-independent differentiation of erythroid progenitors in polycythemia vera., Exp Hematol, 32, 179, 10.1016/j.exphem.2003.11.003 Dupont, 2007, The JAK2 617V>F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera., Blood, 110, 1013, 10.1182/blood-2006-10-054940 Chen, 2008, Trophoblast differentiation defect in human embryonic stem cells lacking PIG-A and GPI-anchored cell-surface proteins., Cell Stem Cell, 2, 345, 10.1016/j.stem.2008.02.004 Yu, 2008, Notch signaling activation in human embryonic stem cells is required for embryonic, but not trophoblastic, lineage commitment., Cell Stem Cell, 2, 461, 10.1016/j.stem.2008.03.001 Ng, 2005, Forced aggregation of defined numbers of human embryonic stem cells into embryoid bodies fosters robust, reproducible hematopoietic differentiation., Blood, 106, 1601, 10.1182/blood-2005-03-0987 Ng, 2008, A protocol describing the use of a recombinant protein-based, animal product-free medium (APEL) for human embryonic stem cell differentiation as spin embryoid bodies., Nat Protoc, 3, 768, 10.1038/nprot.2008.42 Zhan, 2004, Functional antigen-presenting leucocytes derived from human embryonic stem cells in vitro., Lancet, 364, 163, 10.1016/S0140-6736(04)16629-4 Novelli, 1999, Ex vivo culture of cord blood CD34+ cells expands progenitor cell numbers, preserves engraftment capacity in nonobese diabetic/severe combined immunodeficient mice, and enhances retroviral transduction efficiency., Hum Gene Ther, 10, 2927, 10.1089/10430349950016348 Levine, 2008, Myeloproliferative disorders., Blood, 112, 2190, 10.1182/blood-2008-03-077966 Skoda, 2007, The genetic basis of myeloproliferative disorders., Hematology Am Soc Hematol Educ Program, 1 Kralovics, 2002, Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera., Exp Hematol, 30, 229, 10.1016/S0301-472X(01)00789-5 Papayannopoulou, 1979, Hb F production of endogenous colonies of polycythemia vera., Blood, 53, 446, 10.1182/blood.V53.3.446.446 Tiedt, 2008, Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice., Blood, 111, 3931, 10.1182/blood-2007-08-107748 Xing, 2008, Transgenic expression of JAK2V617F causes myeloproliferative disorders in mice., Blood, 111, 5109, 10.1182/blood-2007-05-091579 Olcaydu, 2009, A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms., Nat Genet, 41, 450, 10.1038/ng.341 Kilpivaara, 2009, A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms., Nat Genet, 41, 455, 10.1038/ng.342 Jones, 2009, JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms., Nat Genet, 41, 446, 10.1038/ng.334 Mercier, 2009, Bone marrow mesenchymal stromal cells of patients with myeloproliferative disorders do not carry the JAK2-V617F mutation., Exp Hematol, 37, 416, 10.1016/j.exphem.2008.11.008 Zou, 2009, Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells., Cell Stem Cell, 5, 97, 10.1016/j.stem.2009.05.023 Woltjen, 2009, piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells., Nature, 458, 766, 10.1038/nature07863 Yu, 2009, Human induced pluripotent stem cells free of vector and transgene sequences., Science, 324, 797, 10.1126/science.1172482 Yusa, 2009, Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon., Nat Methods, 6, 363, 10.1038/nmeth.1323 Zhou, 2009, Generation of induced pluripotent stem cells using recombinant proteins., Cell Stem Cell, 4, 381, 10.1016/j.stem.2009.04.005 Kim, 2009, Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins., Cell Stem Cell, 4, 472, 10.1016/j.stem.2009.05.005
Thông tin
Thông tin xuất bản

Blood

Tập 114

5473-5480

Thông tin tác giả